Antigen based therapies to prevent diabetes in NOD mice

Journal of Autoimmunity

Volumn 9, Issue 3, 1996, Pages 349-356

  Ramiya, Vijayakumar K ^a   Shang, Xiao Zhou ^a   Pharis, Peter G ^a   Wasserfall, Clive H ^a   Stabler, Thomas V ^a   Muir, Andrew B ^a   Schatz, Desmond A ^a   Maclaren, Noel K ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Adjuvant; Alum; Antibodies; Cytokines; Diabetes; DTP

Indexed keywords

ADJUVANT; ALUMINUM POTASSIUM SULFATE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; GLUTAMATE DECARBOXYLASE; INSULIN; INSULIN B CHAIN; PEPTIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; IMMUNIZATION; IMMUNOTHERAPY; INSULIN DEPENDENT DIABETES MELLITUS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0030175729     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.1996.0047     Document Type: Conference Paper

References (23)

1. 1. Kaufman D.L., Clare-Salzler M., Tian J., Forsthuber T., Ting G.S.P., Robinson P., Atkinson M.A., Sercarz E.E., Tobin A.J., Lehmann P.V. 1993. Spontaneous loss of T cell self tolerance to glutamate decarboxylase is a key event in the pathogenesis of murine insulin-dependent diabetes. Nature 366: 69-71
2. 2. Muir A., Peck A., Clare-Salzler M., Song Y.-H., Cornelius J., Luchetta R., Krischer J., Maclaren N.K. 1995. Insulin immunization of NOD mice induces a protective insulitis characterized by diminished intra-islet interferon-gamma transcription. J. Clin. Invest. 95: 628-634
3. 3. Ramiya V.K., Muir A.B., Wasserfall C.H., Shang X.-Z., Schott M., Schatz D.A., Krischer J., Maclaren N.K. 1995. Oral and intravenous insulin and glutamic acid decarboxylase to prevent diabetes in NOD mice. J. Autoimmunity. Submitted
4. 4. Weiner H.L., Mackin G.A., Matsui M., Orav E.J., Khoury S.J., Dawson D.M., Hafler D.A. 1993. Double-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis. Science 259: 1321-1324
5. 5. Weiner H.L., Friedman A., Miller A., Khoury S.J., Al-Sabbagh A., Santos L., Sayegh M., Nussenblatt R.B., Trentham D.E., Hafler D.A. 1994. Oral tolerance: immunological mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Annu. Rev. Immunol. 12: 809-837
6. 6. Husby S., Mestecky J., Moldovenanu Z., Holland S., Elson C.O. 1994. Oral tolerance in humans. T cell but not B cell tolerance after antigen feeding. J. Immunol. 152: 4663-4670
7. 67) prevents autoimmune diabetes in NOD mice. Diabetes 43: 1494-1499
8. 8. Atkinson M., Maclaren N., Luchetta R. 1990. Insulitis and diabetes in NOD mice reduced by prophylactic insulin therapy. Diabetes 39: 933-937
9. H1 event. Autoimmunity 15: 113-122
10. 10. Kaplan E.L., Meier P. 1958. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 53: 457-481
11. 11. Mantel N. 1988. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemotherapy Reports 50: 163-170
12. 65 autoantibodies increase the predictability but not the sensitivity of islet cell and insulin autoantibodies for developing insulin dependent diabetes mellitus. J. Autoimmunity 7: 865-872
13. 13. Harrison L.C., Honeyman M.C., Deaizpurua H.J., Schmidli R.S., Colman P.G., Tait B.D., Cram D.S. 1993. Inverse relation between humoral and cellular immunity to glutamic acid decarboxylase in subjects at risk of insulin-dependent diabetes. Lancet 341: 1365-1369
14. 14. Atkinson M.A., Maclaren N.K. 1993. Islet cell autoantigens in insulin-dependent diabetes. J. Clin. Invest. 92: 1608-1616
15. 15. Wegmann D., Norbury-Glaser M., Daniel D. 1994. Insulin-specific T cells are a predominant component of islet infiltrates in pre-diabetic NOD mice. Eur. J. Immunol. 24: 1853-1857
16. 16. Daniel D., Gill R.G., Schloot N., Wegmann D. 1995. Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T clones isolates from. NOD mice. Eur. J. Immunol. 25: 1056-1062
17. 17. Atkinson M.A., Bowman M.A., Campbell L., Kaufman D.L., Maclaren N.K. 1994. Cellular immunity to a determinant common to glutamate decarboxylase and Coxsackie virus in insulin dependent diabetes. J. Clin. Invest. 94: 2125-2129
18. 18. Tian J., Lehmann P.V., Kaufman D.L. 1994. T cell cross-reactivity between Coxsackievirus and glutamate decarboxylase is associated with a murine diabetes susceptibility allele. J. Exp. Med. 180: 1979-1984
19. 19. Chen S.L., Whiteley P.J., Freed D.C., Rothbard J.B., Peterson L.B., Wicker L.S. 1994. Responses of NOD congenic mice to a glutamic acid decarboxylase-derived peptide. J. Autoimmun. 7: 635-641
20. 20. Potter C.W., Tamizifar H., Jennings R. 1995. Immune response of mice to immunization with subunit influenza A vaccine in DTP vaccine. Vaccine 13: 252-260
21. 21. Germann T., Bongartz M., Dlugonska H., Hess H., Schmitt E., Kolbe L., Kolsch E., Podlaski F.J., Gately M.K., Rude E. 1995. Interleukin 12 profoundly up-regulates the synthesis of antigen-specific complement-fixing IgG2A, IgG2B and IgG3 antibody subclasses in vivo. Eur. J. Immunol. 25: 823-829
22. 22. Vaysburd M., Lock C., McDevitt H. 1995. Prevention of insulin-dependent diabetes mellitus in nonobese diabetic mice by immunogenic but not by tolerated peptides. J. Exp. Med. 182: 897-902
23. 23. Kuchroo V.K., Prabhu Das M., Brown J.A., Ranger A.M., Zamvil S.S., Sobel R.A., Weiner H.L., Nabavi N., Glimcher L.H. 1995. B7-1 and B7-2 costimulatory molecules activate differentially the TH1/TH2 developmental pathways: application to autoimmune disease therapy. Cell 80: 707-718